Skip to main content
. Author manuscript; available in PMC: 2015 Dec 20.
Published in final edited form as: Breast Dis. 2010;32(0):5–24. doi: 10.3233/BD-2010-0319

Table 1.

A standard immunohistochemistry (IHC) panel for the three main clinical biomarkers ER, PR, and HER2 can approximate the four intrinsic breast cancer molecular subtypes.

Breast cancer subtype ER PR HER2 Triple designation
Luminal A + ± ER+PR±HER2−
Luminal B + ± + ER+PR±HER2+
HER2+ + ER−PR−HER2+
Basal-like ER−PR−HER2−